About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [698 citations: 101–200 of 660 articles]

Articles published in Prostate Cancer have been cited 698 times. The following is a list of the 660 articles that have cited the articles published in Prostate Cancer.

  • Marc Bienz, and Fred Saad, “Androgen-deprivation therapy and bone loss in prostate cancer patients: a clinical review,” BoneKEy Reports, vol. 4, pp. 716, 2015. View at Publisher · View at Google Scholar
  • Robyn Banerjee, Sang-June Park, Erik Anderson, D. Jeffrey Demanes, Jason Wang, and Mitchell Kamrava, “From whole gland to hemigland to ultra-focal high-dose rate prostate brachytherapy: A dosimetric analysis,” Brachytherapy, 2015. View at Publisher · View at Google Scholar
  • Ann C. Raldow, Danjie Zhang, Ming-Hui Chen, Michelle H. Braccioforte, Brian J. Moran, and Anthony V. D'Amico, “Short-course androgen deprivation therapy and the risk of death from high-risk prostate cancer in men undergoing external beam radiation therapy and brachytherapy,” Brachytherapy, 2015. View at Publisher · View at Google Scholar
  • Jiao Li, Si Zheng, Bin Chen, Atul J. Butte, S. Joshua Swamidass, and Zhiyong Lu, “A survey of current trends in computational drug repositioning,” Briefings in Bioinformatics, vol. 17, no. 1, pp. 2–12, 2015. View at Publisher · View at Google Scholar
  • Lindsey A. Torre, Freddie Bray, Rebecca L. Siegel, Jacques Ferlay, Joannie Lortet-Tieulent, and Ahmedin Jemal, “Global cancer statistics, 2012,” CA: A Cancer Journal for Clinicians, 2015. View at Publisher · View at Google Scholar
  • Hannah K. Weir, Trevor D. Thompson, Ashwini Soman, Bjørn Møller, and Steven Leadbetter, “The past, present, and future of cancer incidence in the United States: 1975 through 2020,” Cancer, 2015. View at Publisher · View at Google Scholar
  • Chad A. Reichard, Andrew J. Stephenson, and Eric A. Klein, “Applying precision medicine to the active surveillance of prostate cancer,” Cancer, 2015. View at Publisher · View at Google Scholar
  • Matteo Santoni, Francesco Piva, Marina Scarpelli, Liang Cheng, Antonio Lopez-Beltran, Francesco Massari, Roberto Iacovelli, Rossana Berardi, Daniele Santini, and Rodolfo Montironi, “The origin of prostate metastases: emerging insights,” Cancer and Metastasis Reviews, 2015. View at Publisher · View at Google Scholar
  • Jeannette M. Schenk, Cathee Till, Ann W. Hsing, Frank Z. Stanczyk, Zhihong Gong, Marian L. Neuhouser, Juergen K. Reichardt, Ashraful M. Hoque, William D. Figg, Phyllis J. Goodman, Catherine M. Tangen, and Ian M. Thompson, “Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial,” Cancer Causes & Control, 2015. View at Publisher · View at Google Scholar
  • Pierrick G.J. Fournier, Patricia Juárez, Guanglong Jiang, Gregory A. Clines, Maria Niewolna, Hun Soo Kim, Holly W. Walton, Xiang Hong Peng, Yunlong Liu, Khalid S. Mohammad, Clark D. Wells, John M. Chirgwin, and Theresa A. Guise, “The TGF-β Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone,” Cancer Cell, 2015. View at Publisher · View at Google Scholar
  • Michael Cheng, Li Zhang, Margaret Borok, Eric Chokunonga, Charles Dzamamala, Anne Korir, Henry R. Wabinga, Robert A. Hiatt, D. Max Parkin, and Katherine Van Loon, “The incidence of oesophageal cancer in Eastern Africa: Identification of a new geographic hot spot?,” Cancer Epidemiology, 2015. View at Publisher · View at Google Scholar
  • Justin B. Emtage, Michael A. Poch, Maisha T. Hutton, and Jerry B. Emtage, “Prostate cancer trends in Barbados: An analysis of the Barbados Urologic Diseases Survey database,” Cancer Epidemiology, vol. 39, no. 6, pp. 825–830, 2015. View at Publisher · View at Google Scholar
  • Kendra Schwartz, Julie J. Ruterbusch, Joanne S. Colt, David C. Miller, Wong-Ho Chow, and Mark P. Purdue, “Racial disparities in overall survival among renal cell carcinoma patients with young age and small tumors,” Cancer Medicine, 2015. View at Publisher · View at Google Scholar
  • Monica Cojoc, Claudia Peitzsch, Ina Kurth, Franziska Trautmann, Leoni A. Kunz-Schughart, Gennady D. Telegeev, Eduard A. Stakhovsky, John R. Walker, Karl Simin, Stephen Lyle, Susanne Fuesse, Kati Erdmann, Manfred P. Wirth, Mechthild Krause, Michael Baumann, and Anna Dubrovska, “Aldehyde Dehydrogenase Is Regulated by beta-Catenin/TCF and Promotes Radioresistance in Prostate Cancer Progenitor Cells,” Cancer Research, vol. 75, no. 7, pp. 1482–1494, 2015. View at Publisher · View at Google Scholar
  • Shanliang Zhong, Xiaohui Zhang, Lin Chen, Tengfei Ma, Jinhai Tang, and Jianhua Zhao, “Statin use and mortality in cancer patients: Systematic review and meta-analysis of observational studies,” Cancer Treatment Reviews, 2015. View at Publisher · View at Google Scholar
  • Tangwei Wu, Weiqun Chen, Deyong Kong, Xiaoyi Li, Hongda Lu, Shuiyi Liu, Jing Wang, Lili Du, Qingzhi Kong, Xiaodong Huang, and Zhongxin Lu, “miR-25 targets the modulator of apoptosis 1 gene in lung cancer,” Carcinogenesis, vol. 36, no. 8, pp. 925–935, 2015. View at Publisher · View at Google Scholar
  • Corina E. Antal, Andrew M. Hudson, Emily Kang, Ciro Zanca, Christopher Wirth, Natalie L. Stephenson, Eleanor W. Trotter, Lisa L. Gallegos, Crispin J. Miller, Frank B. Furnari, Tony Hunter, John Brognard, and Alexandra C. Newton, “Cancer-Associated Protein Kinase C Mutations Reveal Kinase’s Role as Tumor Suppressor,” Cell, 2015. View at Publisher · View at Google Scholar
  • Alexander V. Timoshenko, “Towards molecular mechanisms regulating the expression of galectins in cancer cells under microenvironmental stress conditions,” Cellular and Molecular Life Sciences, 2015. View at Publisher · View at Google Scholar
  • Huai-Hsuan Chiu, Sung-Jeng Tsai, Y. Jane Tseng, Ming-Shiang Wu, Wei-Chih Liao, Chiun-Sheng Huang, and Ching-Hua Kuo, “An efficient and robust fatty acid profiling method for plasma metabolomic studies by gas chromatography–mass spectrometry,” Clinica Chimica Acta, 2015. View at Publisher · View at Google Scholar
  • Ziauddin Zia Saad, and John R. Buscombe, “Sentinel lymph node: established and new areas of use,” Clinical and Translational Imaging, 2015. View at Publisher · View at Google Scholar
  • Bi-Dar Wang, Kristin Ceniccola, Qi Yang, Ramez Andrawis, Vyomesh Patel, Youngmi Ji, Johng Rhim, Jacqueline Olender, Anastas Popratiloff, Patricia Latham, Yinglei Lai, Steven R. Patierno, and Norman H. Lee, “Identification and Functional Validation of Reciprocal microRNA-mRNA Pairings in African American Prostate Cancer Disparities,” Clinical Cancer Research, vol. 21, no. 21, pp. 4970–4984, 2015. View at Publisher · View at Google Scholar
  • Pier-Luc Clermont, Dong Lin, Francesco Crea, Rebecca Wu, Hui Xue, Yuwei Wang, Kelsie L Thu, Wan L Lam, Colin C Collins, Yuzhuo Wang, and Cheryl D Helgason, “Polycomb-mediated silencing in neuroendocrine prostate cancer,” Clinical Epigenetics, vol. 7, no. 1, 2015. View at Publisher · View at Google Scholar
  • Bistra Galunska, Daniela Gerova, Petar Kosev, Deyan Anakievski, and Alexander Hinev, “Serum 25-Hydroxy Vitamin D Levels in Bulgarian Patients with Prostate Cancer: a Pilot Study,” Clinical Laboratory, vol. 61, no. 3-4, pp. 329–335, 2015. View at Publisher · View at Google Scholar
  • Rhonda Arthur, Alejo Rodríguez-Vida, Giorgia Zadra, Henrik Møller, and Mieke Van Hemelrijck, “Serum lipids as markers of prostate cancer occurrence and prognosis?,” Clinical Lipidology, vol. 10, no. 2, pp. 145–165, 2015. View at Publisher · View at Google Scholar
  • N. Somaiah, K. Rothkamm, and J. Yarnold, “Where Do We Look for Markers of Radiotherapy Fraction Size Sensitivity?,” Clinical Oncology, 2015. View at Publisher · View at Google Scholar
  • Jonathan C. Dunne, David S. Lamb, Brett Delahunt, Judith Murray, Peter Bethwaite, Peter Ferguson, John N. Nacey, Sven Sondhauss, and T. William Jordan, “Proteins from formalin-fixed paraffin-embedded prostate cancer sections that predict the risk of metastatic disease,” Clinical Proteomics, vol. 12, no. 1, 2015. View at Publisher · View at Google Scholar
  • Jgc van Hasselt, A Gupta, Z Hussein, Jh Beijnen, Jhm Schellens, and Adr Huitema, “Disease Progression/Clinical Outcome Model for Castration-Resistant Prostate Cancer in Patients Treated With Eribulin,” CPT: Pharmacometrics & Systems Pharmacology, 2015. View at Publisher · View at Google Scholar
  • Kirk M. Anderson, Maxx Gallegos, Ty T. Higuchi, and Brian J. Flynn, “Evaluation and Management of Rectourethral Fistulas After Prostate Cancer Treatment,” Current Bladder Dysfunction Reports, 2015. View at Publisher · View at Google Scholar
  • Divaya Bhutani, and Lawrence G. Lum, “Activated T cells armed with bispecific antibodies kill tumor targets,” Current Opinion in Hematology, vol. 22, no. 6, pp. 476–483, 2015. View at Publisher · View at Google Scholar
  • Marc Bienz, and Fred Saad, “Management of bone metastases in prostate cancer,” Current Opinion in Supportive and Palliative Care, vol. 9, no. 3, pp. 261–267, 2015. View at Publisher · View at Google Scholar
  • Jonathan A. Coleman, “Functional outcomes of partial prostate ablation and focal therapy,” Current Opinion in Urology, vol. 25, no. 3, pp. 220–224, 2015. View at Publisher · View at Google Scholar
  • V. Kasivisvanathan, T.T. Shah, I. Donaldson, A. Kanthabalan, C.M. Moore, M. Emberton, and H.U. Ahmed, “Fokale Therapie des Prostatakarzinoms,” Der Urologe, vol. 54, no. 2, pp. 202–209, 2015. View at Publisher · View at Google Scholar
  • Jieke Yan, Yuzhen Wang, Xufeng Zhang, Shuangde Liu, Chuan Tian, and Hongwei Wang, “ Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid–polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo ,” Drug Delivery, pp. 1–6, 2015. View at Publisher · View at Google Scholar
  • C. Reviriego, “ARN-509 Androgen receptor signaling inhibitor Prostate cancer therapy,” Drugs Of The Future, vol. 40, no. 2, pp. 101–108, 2015. View at Publisher · View at Google Scholar
  • Federica Finetti, Erika Terzuoli, Antonio Giachetti, Raffaella Santi, Donata Villari, Hiromi Hanaka, Olof Radmark, Marina Ziche, and Sandra Donnini, “mPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity,” Endocrine-Related Cancer, vol. 22, no. 4, pp. 665–678, 2015. View at Publisher · View at Google Scholar
  • Emma H Allott, and Stephen D Hursting, “Obesity and cancer: mechanistic insights from transdisciplinary studies,” Endocrine-Related Cancer, vol. 22, no. 6, pp. R365–R386, 2015. View at Publisher · View at Google Scholar
  • J. M. Devaney, S. Wang, P. Furbert-Harris, V. Apprey, M. Ittmann, B-D Wang, J. Olender, N. H. Lee, and B. Kwabi-Addo, “Genome-wide differentially methylated genes in prostate cancer tissues from African-American and Caucasian men,” Epigenetics, vol. 10, no. 4, pp. 319–328, 2015. View at Publisher · View at Google Scholar
  • Kazuhiro Ohwaki, Fumiyasu Endo, and Kazunori Hattori, “Abdominal obesity, hypertension, antihypertensive medication use and biochemical recurrence of prostate cancer after radical prostatectomy,” European Journal of Cancer, 2015. View at Publisher · View at Google Scholar
  • Mohamed Jalloh, Frank Myers, Janet E. Cowan, Peter R. Carroll, and Matthew R. Cooperberg, “Racial Variation in Prostate Cancer Upgrading and Upstaging Among Men with Low-risk Clinical Characteristics,” European Urology, vol. 67, no. 3, pp. 451–457, 2015. View at Publisher · View at Google Scholar
  • Fred Saad, Neal Shore, Hendrik Van Poppel, Dana E. Rathkopf, Matthew R. Smith, Johann S. de Bono, Christopher J. Logothetis, Paul de Souza, Karim Fizazi, Peter F.A. Mulders, Paul Mainwaring, John D. Hainsworth, Tomasz M. Beer, Scott North, Yves Fradet, Thomas A. Griffin, Peter De Porre, Anil Londhe, Thian Kheoh, Eric J. Small, Howard I. Scher, Arturo Molina, and Charles J. Ryan, “Impact of Bone-targeted Therapies in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer Patients Treated with Abiraterone Acetate: Post Hoc Analysis of Study COU-AA-302,” European Urology, 2015. View at Publisher · View at Google Scholar
  • Francesca Khani, and Brian D. Robinson, “A “Chicken or Egg” Conundrum: Race, Molecular Subtype, and Tumor Location in Prostate Cancer,” European Urology, 2015. View at Publisher · View at Google Scholar
  • Roderick C.N. van den Bergh, Niels J. van Casteren, Thomas van den Broeck, Eve R. Fordyce, William K.M. Gietzmann, Fiona Stewart, Steven MacLennan, Saeed Dabestani, Joaquim Bellmunt, Michel Bolla, Erik Briers, Philip Cornford, Steven Joniau, Malcolm D. Mason, Vsevolod Matveev, Henk G. van der Poel, Theo H. van der Kwast, Olivier Rouvière, Thomas Wiegel, Thomas B. Lam, and Nicolas Mottet, “Role of Hormonal Treatment in Prostate Cancer Patients with Nonmetastatic Disease Recurrence After Local Curative Treatment: A Systematic Review,” European Urology, 2015. View at Publisher · View at Google Scholar
  • Stéphane Oudard, Pablo Maroto, Gaston Demonty, and Winald R. Gerritsen, “Charting Recent Progress and Challenges in Metastatic Castration-resistant Prostate Cancer: Is There an Optimal Treatment Sequence?,” European Urology Focus, 2015. View at Publisher · View at Google Scholar
  • Yingjie Cao, Xinzhong Huang, Yaping Fan, and Xiaolan Chen, “ Protective Effect of Triptolide against Glomerular Mesangial Cell Proliferation and Glomerular Fibrosis in Rats Involves the TGF- β 1/Smad Signaling Pathway ,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, pp. 1–10, 2015. View at Publisher · View at Google Scholar
  • Yan Zhu, Chengshan Li, Aichen Su, Yuanye Wang, and Shengnian Zhou, “Quantification of microRNA-210 in the cerebrospinal fluid and serum: Implications for Alzheimer's disease,” Experimental and Therapeutic Medicine, 2015. View at Publisher · View at Google Scholar
  • Jun Guo, Shu-Hong Wu, Wei-Guo Ren, Xin-Li Wang, and Ai-Qing Yang, “Anticancer activity of bicalutamide-loaded PLGA nanoparticles in prostate cancers,” Experimental And Therapeutic Medicine, vol. 10, no. 6, pp. 2305–2310, 2015. View at Publisher · View at Google Scholar
  • Yong Gao, Puxian Li, Zhenrui Liu, Xingtao Diao, and Chunyun Song, “Expression levels of vascular endothelial cell growth factor and microRNA-210 are increased in medulloblastoma and metastatic medulloblastoma,” Experimental And Therapeutic Medicine, vol. 10, no. 6, pp. 2138–2144, 2015. View at Publisher · View at Google Scholar
  • Kenneth C Valkenburg, and Kenneth J Pienta, “Drug discovery in prostate cancer mouse models,” Expert Opinion on Drug Discovery, pp. 1–14, 2015. View at Publisher · View at Google Scholar
  • Alexandru Dan Grigore, Eshel Ben-Jacob, and Mary C. Farach-Carson, “Prostate Cancer and Neuroendocrine Differentiation: More Neuronal, Less Endocrine?,” Frontiers in Oncology, vol. 5, 2015. View at Publisher · View at Google Scholar
  • Kashyap Shatagopam, Hristos Z. Kaimakliotis, Liang Cheng, and Michael O. Koch, “Genitourinary small cell malignancies: prostate and bladder,” Future Oncology, vol. 11, no. 3, pp. 479–488, 2015. View at Publisher · View at Google Scholar
  • Andreas G Wibmer, Hebert Alberto Vargas, and Hedvig Hricak, “Role of MRI in the diagnosis and management of prostate cancer,” Future Oncology, 2015. View at Publisher · View at Google Scholar
  • Y. Zhao, J. Liang, J. G. Qi, N. Yang, G. Wu, Y. L. Lin, J. Y. Cao, Q. Wang, and Q. C. Wang, “Meta-analysis of the association between the HNF1B rs4430796 (A>G) polymorphism and risk of prostate cancer based on case-control studies,” Genetics And Molecular Research, vol. 14, no. 3, pp. 7426–7435, 2015. View at Publisher · View at Google Scholar
  • Atsushi Imai, Kazutoshi Matsunami, Satoshi Ichigo, and Hiroshi Takagi, “Minodronic acid suppresses gonadotropin-releasing hormone agonist-induced bone remodeling biomarkers: a retrospective pilot study,” Gynecological Endocrinology, pp. 1–3, 2015. View at Publisher · View at Google Scholar
  • Craig R. Ramsay, Temitope E. Adewuyi, Joanne Gray, Jenni Hislop, Mark D. F. Shirley, Shalmini Jayakody, Graeme MacLennan, Cynthia Fraser, Sara MacLennan, Miriam Brazzelli, James N'Dow, Robert Pickard, Clare Robertson, Kieran Rothnie, Stephen P. Rushton, Luke Vale, and Thomas B. Lam, “Ablative therapy for people with localised prostate cancer: a systematic review and economic evaluation,” Health Technology Assessment, vol. 19, no. 49, pp. 1–+, 2015. View at Publisher · View at Google Scholar
  • Michael J Hall, Karen J Ruth, David YT Chen, Laura M Gross, and Veda N Giri, “Interest in genomic SNP testing for prostate cancer risk: a pilot survey,” Hereditary Cancer in Clinical Practice, vol. 13, no. 1, 2015. View at Publisher · View at Google Scholar
  • David C. Qian, Jinyoung Byun, Younghun Han, Casey S. Greene, John K. Field, Rayjean J. Hung, Yonathan Brhane, John R. Mclaughlin, Gordon Fehringer, Maria Teresa Landi, Albert Rosenberger, Heike Bickeböller, Jyoti Malhotra, Angela Risch, Joachim Heinrich, David J. Hunter, Brian E. Henderson, Christopher A. Haiman, Fredrick R. Schumacher, Rosalind A. Eeles, Douglas F. Easton, Daniela Seminara, and Christopher I. Amos, “Identification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein interactions,” Human Molecular Genetics, pp. ddv440, 2015. View at Publisher · View at Google Scholar
  • Stefan G. Schalk, Libertario Demi, Martijn Smeenge, David M. Mills, Kirk D. Wallace, Jean J. M. C. H. de la Rosette, Hessel Wijkstra, and Massimo Mischi, “4-D spatiotemporal analysis of ultrasound contrast agent dispersion for prostate cancer localization: a feasibility study,” IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control, vol. 62, no. 5, pp. 839–851, 2015. View at Publisher · View at Google Scholar
  • Monika Izano, Esther K. Wei, Caroline Tai, Helen Swede, Steven Gregorich, Tamara B. Harris, Heidi Klepin, Suzanne Satterfield, Rachel Murphy, Anne B. Newman, Susan M. Rubin, and Dejana Braithwaite, “Chronic inflammation and risk of colorectal and other obesity-related cancers: The health, aging and body composition study,” International Journal of Cancer, 2015. View at Publisher · View at Google Scholar
  • S. Faithfull, A. Lemanska, P. Aslet, N. Bhatt, J. Coe, L. Drudge-Coates, M. Feneley, R. Glynn-Jones, M. Kirby, S. Langley, T. McNicholas, J. Newman, C. C. Smith, A. Sahai, E. Trueman, and H. Payne, “Integrative review on the non-invasive management of lower urinary tract symptoms in men following treatments for pelvic malignancies,” International Journal of Clinical Practice, 2015. View at Publisher · View at Google Scholar
  • M. Gierth, S. Denzinger, G. Liebig-Hörl, M. Burger, and A. Fürst, “Management of rectourinary fistula after urological interventions using biodesigned mesh: first experiences of an innovative technique,” International Journal of Colorectal Disease, 2015. View at Publisher · View at Google Scholar
  • Stefano Marventano, Paulina Kolacz, Sabrina Castellano, Fabio Galvano, Silvio Buscemi, Antonio Mistretta, and Giuseppe Grosso, “A review of recent evidence in human studies of n-3 and n-6 PUFA intake on cardiovascular disease, cancer, and depressive disorders: does the ratio re,” International Journal Of Food Sciences And Nutrition, vol. 66, no. 6, pp. 611–622, 2015. View at Publisher · View at Google Scholar
  • Eva Tvrda, Ashok Agarwal, and Nawaf Alkuhaimi, “Male Reproductive Cancers and Infertility: A Mutual Relationship,” International Journal Of Molecular Sciences, vol. 16, no. 4, pp. 7230–7260, 2015. View at Publisher · View at Google Scholar
  • Stefania Clemente, Roberta Nigro, Caterina Oliviero, Chiara Marchioni, Marco Esposito, Francesca Romana Giglioli, Pietro Mancosu, Carmelo Marino, Serenella Russo, Michele Stasi, Lidia Strigari, Ivan Veronese, and Valeria Landoni, “Role of the Technical Aspects of Hypofractionated Radiation Therapy Treatment of Prostate Cancer: A Review,” International Journal of Radiation Oncology*Biology*Physics, vol. 91, no. 1, pp. 182–195, 2015. View at Publisher · View at Google Scholar
  • Jeffrey A. Kittel, Chandana A. Reddy, Kristin L. Smith, Kevin L. Stephans, Rahul D. Tendulkar, James Ulchaker, Kenneth Angermeier, Steven Campbell, Andrew Stephenson, Eric A. Klein, D. Allan Wilkinson, and Jay P. Ciezki, “Long-Term Efficacy and Toxicity of Low-Dose-Rate 125I Prostate Brachytherapy as Monotherapy in Low-, Intermediate-, and High-Risk Prostate Cancer,” International Journal of Radiation Oncology*Biology*Physics, 2015. View at Publisher · View at Google Scholar
  • Victoria A. Harris, John Staffurth, Olivia Naismith, Alikhan Esmail, Sarah Gulliford, Vincent Khoo, Rebecca Lewis, John Littler, Helen McNair, Azmat Sadoyze, Christopher Scrase, Aslam Sohaib, Isabel Syndikus, Anjali Zarkar, Emma Hall, and David Dearnaley, “Consensus Guidelines and Contouring Atlas for Pelvic Node Delineation in Prostate and Pelvic Node Intensity Modulated Radiation Therapy,” International Journal of Radiation Oncology*Biology*Physics, vol. 92, no. 4, pp. 874–883, 2015. View at Publisher · View at Google Scholar
  • Yugo Sawada, Kazuya Omoto, Naoki Kohei, Kengo Sakaguchi, Masahiko Miura, and Kazunari Tanabe, “Sulfoquinovosylacylpropanediol is a novel potent radiosensitizer in prostate cancer,” International Journal of Urology, 2015. View at Publisher · View at Google Scholar
  • Cenk Acar, Gijs H Kleinjan, Nynke S van den Berg, Esther MK Wit, Fijs WB van Leeuwen, and Henk G van der Poel, “Advances in sentinel node dissection in prostate cancer from a technical perspective,” International Journal of Urology, 2015. View at Publisher · View at Google Scholar
  • Wan Song, Hwang Gyun Jeon, Hyun Hwan Sung, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Han Yong Choi, and Hyun Moo Lee, “Prognostic factors after salvage radiotherapy alone in patients with biochemical recurrence after radical prostatectomy,” International Journal of Urology, 2015. View at Publisher · View at Google Scholar
  • Xiaopeng Jia, Yanan Sun, and Baozhi Wang, “Gray level entropy matrix is a superior predictor than multiplex ELISA in the detection of reactive stroma and metastatic potential of high-grade prostatic adenocarcinoma,” IUBMB Life, 2015. View at Publisher · View at Google Scholar
  • Takanobu Utsumi, Ryo Oka, Takumi Endo, Masashi Yano, Shuichi Kamijima, Naoto Kamiya, Masaaki Fujimura, Nobuyuki Sekita, Kazuo Mikami, Nobuyuki Hiruta, and Hiroyoshi Suzuki, “External validation and comparison of two nomograms predicting the probability of Gleason sum upgrading between biopsy and radical prostatectomy pathology in two patient populations: a retrospective cohort study,” Japanese Journal of Clinical Oncology, pp. hyv128, 2015. View at Publisher · View at Google Scholar
  • Camella J Rising, Nadine Bol, and Gary L Kreps, “Age-Related Use and Perceptions of eHealth in Men With Prostate Cancer: A Web-Based Survey,” JMIR Cancer, vol. 1, no. 1, pp. e6, 2015. View at Publisher · View at Google Scholar
  • Kei Sasaki, Hirofumi Miyata, Hiroto Sasaki, Siu Kang, Tetsuya Yuasa, and Ryuji Kato, “Image-based focused counting of dividing cells for non-invasive monitoring of regenerative medicine products,” Journal of Bioscience and Bioengineering, 2015. View at Publisher · View at Google Scholar
  • Linda Fleisher, Stacy N. Davis, Laura Gross, Loretta Bagden, Debra Zakrzewski, Evelyn González, Venk Kandadai, Cheryl Rusten, Jerilyn Baskett, Elias Obeid, and Veda N. Giri, “Lessons Learned from Implementing a Prostate Cancer Risk Assessment Program for Underserved High-Risk Men in the Community: the Prostate REACH Project,” Journal of Cancer Education, 2015. View at Publisher · View at Google Scholar
  • Olakanmi Ralph Akinde, Adekoyejo Abiodun Phillips, Olubanji Ajibola Oguntunde, and Olatunji Michael Afolayan, “Cancer Mortality Pattern in Lagos University Teaching Hospital, Lagos, Nigeria,” Journal of Cancer Epidemiology, vol. 2015, pp. 1–6, 2015. View at Publisher · View at Google Scholar
  • Isaac Eliaz, Elaine Weil, Julie-Ann Dutton, Audrey E. McCalley, Barbie Nolte, and Patrick M. Moriarty, “Lipoprotein apheresis reduces circulating galectin-3 in humans,” Journal of Clinical Apheresis, 2015. View at Publisher · View at Google Scholar
  • Matthew D. Christensen, Jacob J. Elmer, Seron Eaton, Laura Gonzalez-Malerva, Joshua LaBaer, and Kaushal Rege, “Kinome-level screening identifies inhibition of polo-like kinase-1 (PLK1) as a target for enhancing non-viral transgene expression,” Journal of Controlled Release, vol. 204, pp. 20–29, 2015. View at Publisher · View at Google Scholar
  • Yuan-Qing Fu, Ju-Sheng Zheng, Bo Yang, and Duo Li, “Effect of Individual Omega-3 Fatty Acids on the Risk of Prostate Cancer: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Stu,” Journal Of Epidemiology, vol. 25, no. 4, pp. 261–274, 2015. View at Publisher · View at Google Scholar
  • Shinobu Watanabe-Galloway, Kate Watkins, and Tinka Duran, “Trends and Patterns of Late and Unstaged Lung, Colorectal, Female Breast, and Prostate Cancers among American Indians in the Northern Plains, 2002-200,” Journal Of Health Care For The Poor And Underserved, vol. 26, no. 3, pp. 1048–1066, 2015. View at Publisher · View at Google Scholar
  • Rachel E. Crossland, Jean Norden, Louis A. Bibby, Joanna Davis, and Anne M. Dickinson, “Evaluation of optimal extracellular vesicle small RNA isolation and qRT-PCR normalisation for serum and urine samples,” Journal of Immunological Methods, 2015. View at Publisher · View at Google Scholar
  • Hye Won Lee, Hwang Gyun Jeon, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Hyun Moo Lee, and Han Yong Choi, “Is Radical Perineal Prostatectomy a Viable Therapeutic Option for Intermediate- and High-risk Prostate Cancer?,” Journal of Korean Medical Science, vol. 30, no. 11, pp. 1631, 2015. View at Publisher · View at Google Scholar
  • Asha Singanamalli, Mirabela Rusu, Rachel E. Sparks, Natalie N.C. Shih, Amy Ziober, Li-Ping Wang, John Tomaszewski, Mark Rosen, Michael Feldman, and Anant Madabhushi, “Identifying in vivo DCE MRI markers associated with microvessel architecture and gleason grades of prostate cancer,” Journal of Magnetic Resonance Imaging, 2015. View at Publisher · View at Google Scholar
  • Shea William Wilcox, Noel J. Aherne, Craig Steven McLachlan, Michael J. McKay, Andrew J. Last, and Thomas P. Shakespeare, “Is modern external beam radiotherapy with androgen deprivation therapy still a viable alternative for prostate cancer in an era of robotic surgery and brachytherapy: A comparison of Australian series,” Journal of Medical Imaging and Radiation Oncology, 2015. View at Publisher · View at Google Scholar
  • Jan Tykvart, Jiri Schimer, Andrej Jancarik, Jitka Barinkova, Vaclav Navratil, Jana Starkova, Karolina Sramkova, Jan Konvalinka, Pavel Majer, and Pavel Sacha, “Design of highly potent urea-based, exosite-binding inhibitors selective for glutamate carboxypeptidase II,” Journal of Medicinal Chemistry, pp. 150429121122000, 2015. View at Publisher · View at Google Scholar
  • Margot K. Davis, Jennifer L. Rajala, Scott Tyldesley, Tom Pickles, and Sean A. Virani, “The Prevalence of Cardiac Risk Factors in Men with Localized Prostate Cancer Undergoing Androgen Deprivation Therapy in British Columbia, Canada,” Journal of Oncology, vol. 2015, pp. 1–7, 2015. View at Publisher · View at Google Scholar
  • Pandi Anandakumar, Sattu Kamaraj, Sundaram Jagan, Gopalakrishnan Ramakrishnan, Selvamani Asokkumar, Chandrashekar Naveenkumar, Subramanian Raghunandhakumar, Manickam Kalappan Vanitha, and Thiruvengadam Devaki, “The Anticancer Role of Capsaicin in Experimentallyinduced Lung Carcinogenesis,” Journal of Pharmacopuncture, vol. 18, no. 2, pp. 19–25, 2015. View at Publisher · View at Google Scholar
  • Wen P. Liu, Jeremy D. Richmon, Jonathan M. Sorger, Mahdi Azizian, and Russell H. Taylor, “Augmented reality and cone beam CT guidance for transoral robotic surgery,” Journal of Robotic Surgery, 2015. View at Publisher · View at Google Scholar
  • S. S. Goonewardene, R. Persad, and D Gillatt, “Penile rehabilitation for robotic radical prostatectomy: a new game,” Journal of Robotic Surgery, 2015. View at Publisher · View at Google Scholar
  • Daniel Ramirez, Homayoun Zargar, Peter Caputo, and Jihad H. Kaouk, “Robotic-assisted laparoscopic prostatectomy: An update on functional and oncologic outcomes, techniques, and advancements in technology,” Journal of Surgical Oncology, 2015. View at Publisher · View at Google Scholar
  • Mihai Tanase, and Przemyslaw Waliszewski, “On complexity and homogeneity measures in predicting biological aggressiveness of prostate cancer; Implication of the cellular automata model of tumor growth,” Journal of Surgical Oncology, 2015. View at Publisher · View at Google Scholar
  • Michael T. Dinwiddie, Paul D. Terry, Jay Whelan, and Rachel E. Patzer, “Omega-3 Fatty Acid Consumption and Prostate Cancer: A Review of Exposure Measures and Results of Epidemiological Studies,” Journal of the American College of Nutrition, pp. 1–17, 2015. View at Publisher · View at Google Scholar
  • Andrew W Bazemore, Erika K Cottrell, Rachel Gold, Lauren S Hughes, Robert L Phillips, Heather Angier, Timothy E Burdick, Mark A Carrozza, and Jennifer E DeVoe, “ “Community Vital Signs” : Incorporating geocoded social determinants into electronic records to promote patient and population health ,” Journal of the American Medical Informatics Association, pp. ocv088, 2015. View at Publisher · View at Google Scholar
  • Won Park, “Radiotherapy for prostate cancer,” Journal of the Korean Medical Association, vol. 58, no. 1, pp. 21, 2015. View at Publisher · View at Google Scholar
  • Nathan Bucay, Varahram Shahryari, Shahana Majid, Soichiro Yamamura, Yozo Mitsui, Z. Laura Tabatabai, Kirsten Greene, Guoren Deng, Rajvir Dahiya, Yuichiro Tanaka, and Sharanjot Saini, “miRNA Expression Analyses in Prostate Cancer Clinical Tissues,” Jove-Journal Of Visualized Experiments, no. 103, 2015. View at Publisher · View at Google Scholar
  • Wan Song, and Hwang Gyun Jeon, “Incidence of kidney, bladder, and prostate cancers in Korea: An update,” Korean Journal of Urology, vol. 56, no. 6, pp. 422, 2015. View at Publisher · View at Google Scholar
  • Jiule Ding, Jie Chen, Zhenxing Jiang, Hua Zhou, Jia Di, Shijun Xing, and Wei Xing, “Is low b-factors-based apparent diffusion coefficient helpful in assessing renal dysfunction?,” La radiologia medica, 2015. View at Publisher · View at Google Scholar
  • Michael Politis, Gladys Higuera, Lissette Raquel Chang, Beatriz Gomez, Juan Bares, and Jorge Motta, “Trend Analysis of Cancer Mortality and Incidence in Panama, Using Joinpoint Regression Analysis,” Medicine, vol. 94, no. 24, pp. e970, 2015. View at Publisher · View at Google Scholar
  • You Luo, Dong-Li She, Hu Xiong, Sheng-Jun Fu, and Li Yang, “The Prognostic Effect of Statin Use on Urologic Cancers An Updated Meta-Analysis of 35 Observational Studies,” Medicine, vol. 94, no. 36, 2015. View at Publisher · View at Google Scholar
  • Julie A. Rytlewski, M. Alejandra Aldon, Evan W. Lewis, and Laura J. Suggs, “Mechanisms of Tubulogenesis and Endothelial Phenotype Expression by MSCs,” Microvascular Research, 2015. View at Publisher · View at Google Scholar
  • Ryu Nakadate, Jumpei Arata, and Makoto Hashizume, “Next-generation robotic surgery - from the aspect of surgical robots developed by industry,” Minimally Invasive Therapy & Allied Technologies, vol. 24, no. 1, pp. 2–7, 2015. View at Publisher · View at Google Scholar
  • Lin Zhang, Shuping Yang, Xingcheng Chen, Seth Stauffer, Fang Yu, Subodh M. Lele, Kai Fu, Kaustubh Datta, Nicholas Palermo, Yuanhong Chen, and Jixin Dong, “The Hippo Pathway Effector YAP Regulates Motility, Invasion, and Castration-Resistant Growth of Prostate Cancer Cells,” Molecular And Cellular Biology, vol. 35, no. 8, pp. 1350–1362, 2015. View at Publisher · View at Google Scholar